BX Swiss TOP 30 CHF
1.270,79
PKT
+9,69
PKT
+0,77
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.01.16 | Zurich Insurance Neutral | BNP PARIBAS | |
| 22.01.16 | Novartis buy | UBS AG | |
| 22.01.16 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 22.01.16 | Richemont Outperform | Credit Suisse Group | |
| 22.01.16 | Swiss Re buy | Citigroup Corp. | |
| 21.01.16 | Zurich Insurance Sell | S&P Capital IQ | |
| 21.01.16 | Zurich Insurance Sell | Société Générale Group S.A. (SG) | |
| 21.01.16 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.16 | Richemont buy | HSBC | |
| 21.01.16 | Zurich Insurance Hold | Deutsche Bank AG | |
| 21.01.16 | Zurich Insurance kaufen | Bankhaus Lampe KG | |
| 21.01.16 | Zurich Insurance Neutral | UBS AG | |
| 21.01.16 | Zurich Insurance Outperform | Credit Suisse Group | |
| 20.01.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 20.01.16 | Zurich Insurance Verkaufen | DZ-Bank AG | |
| 19.01.16 | Richemont kaufen | Independent Research GmbH | |
| 19.01.16 | Richemont buy | UBS AG | |
| 19.01.16 | Holcim Neutral | UBS AG | |
| 19.01.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.01.16 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 18.01.16 | UBS buy | Citigroup Corp. | |
| 18.01.16 | Richemont buy | Goldman Sachs Group Inc. | |
| 15.01.16 | Richemont overweight | Morgan Stanley | |
| 15.01.16 | Richemont Outperform | Bernstein Research | |
| 15.01.16 | Nestlé Equal weight | Barclays Capital | |
| 15.01.16 | Roche overweight | Barclays Capital | |
| 15.01.16 | Novartis Underweight | Barclays Capital | |
| 15.01.16 | Richemont overweight | JP Morgan Chase & Co. | |
| 15.01.16 | Holcim Neutral | BNP PARIBAS | |
| 14.01.16 | Richemont buy | S&P Capital IQ | |
| 14.01.16 | UBS Outperform | RBC Capital Markets | |
| 14.01.16 | UBS Sell | Société Générale Group S.A. (SG) | |
| 14.01.16 | UBS Market Perform | Cowen and Company, LLC | |
| 14.01.16 | Roche buy | Jefferies & Company Inc. | |
| 14.01.16 | Novartis buy | Jefferies & Company Inc. | |
| 14.01.16 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 14.01.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 14.01.16 | UBS Neutral | Credit Suisse Group | |
| 13.01.16 | UBS overweight | Morgan Stanley | |
| 13.01.16 | UBS overweight | Morgan Stanley |